Applied Epidemiology & Disease Control

Complete Health Loksewa notes

Applied Epidemiology & Disease Control

An in-depth exploration of communicable and non-communicable diseases, genetic disorders like Sickle Cell, and the spectrum of disease eradication. Featuring advanced epidemiological infographics.

6.1 Communicable Diseases: Epidemiology & Control

Communicable diseases are illnesses caused by infectious agents or their toxins that arise through direct or indirect transmission from an infected person, animal, or reservoir to a susceptible host. Effective control requires a deep understanding of the epidemiological triad and breaking specific links in the chain of infection.

The Epidemiological Triad

Disease occurs at the intersection of these three factors. Interventions target one or more to prevent transmission.

Breaking the Chain of Infection

Targeting the Agent: Using antibiotics, antivirals, or disinfecting surfaces to destroy the pathogen directly.
Targeting the Host: Administering vaccines to increase immunity, promoting good nutrition, and isolating susceptible individuals.
Targeting the Environment: Improving sanitation (WASH), draining stagnant water to kill mosquito larvae, and ensuring safe housing/ventilation.

Disease Category	Key Examples Covered	Primary Control Measure
Vaccine-Preventable	Measles, Diphtheria, Pertussis, Tetanus, Rubella, Mumps	Routine Immunization (EPI program)
Vector-Borne	Malaria, Japanese Encephalitis, Filaria, Leishmaniasis	Vector control (LLINs, IRS), Environmental sanitation
Water/Food-Borne	Typhoid, Food Poisoning, Acute Diarrhea, Intestinal worms	WASH (Water, Sanitation, Hygiene), Food safety
Respiratory/Droplet	TB, ARI, Influenza, COVID-19	Isolation, Masks, DOTS (for TB), Vaccination
Contact/Zoonotic	Rabies, Leprosy, STD, HIV/AIDS, Hepatitis	Post-exposure prophylaxis, Safe sex, Multi-drug therapy

Individual Disease Profiles

Measles

Agent: Paramyxovirus (RNA Virus)

Transmission: Airborne respiratory droplets. Highly contagious (R0 12-18).

Key Signs: Koplik’s spots (mouth), descending maculopapular rash, high fever, coryza.

Control: Live attenuated MMR Vaccine (requires >95% coverage for herd immunity).

Diphtheria

Agent: Corynebacterium diphtheriae (Bacteria)

Transmission: Respiratory droplets and close physical contact.

Key Signs: Thick, grey pseudomembrane covering the tonsils/throat, massive neck swelling (“bull neck”).

Control: DPT/Pentavalent Vaccine; Diphtheria antitoxin for acute treatment.

Whooping Cough (Pertussis)

Agent: Bordetella pertussis (Bacteria)

Transmission: Airborne respiratory droplets.

Key Signs: Severe paroxysmal coughing fits ending in a high-pitched inspiratory “whoop”.

Control: DPT/Pentavalent Vaccine; prophylactic antibiotics for close contacts.

Acute Respiratory Infection (ARI)

Agent: Various (RSV, Streptococcus pneumoniae, Hib)

Transmission: Droplet spread, contact with contaminated fomites.

Key Signs: Fast breathing, lower chest wall indrawing, stridor, cough, fever. Leading cause of under-5 child mortality.

Control: Pneumococcal (PCV) & Hib vaccines, improved indoor air quality, early antibiotic use for pneumonia.

Rubella (German Measles)

Agent: Rubella virus (Togavirus)

Transmission: Airborne respiratory droplets and vertical (mother-to-fetus).

Key Signs: Mild rash in children. In early pregnancy, causes Congenital Rubella Syndrome (CRS) leading to fetal cataracts, deafness, and heart defects.

Control: MMR Vaccine.

Mumps

Agent: Mumps virus (Paramyxovirus)

Transmission: Direct contact with saliva or respiratory droplets.

Key Signs: Painful swelling of one or both parotid salivary glands. Can cause orchitis (testicular inflammation) in post-pubertal males.

Control: MMR Vaccine.

Influenza (Flu)

Agent: Influenza virus (A, B, C)

Transmission: Droplet spread, aerosols, and contaminated surfaces.

Key Signs: Sudden high fever, severe myalgia (muscle aches), exhaustion, dry cough. Capable of pandemic spread via antigenic shift.

Control: Annual seasonal influenza vaccination, antiviral drugs (Oseltamivir).

Tuberculosis (TB)

Agent: Mycobacterium tuberculosis

Transmission: Airborne droplet nuclei (coughing/sneezing).

Key Signs: Chronic cough (>2 weeks), hemoptysis (coughing blood), night sweats, progressive weight loss.

Control: DOTS Strategy (Directly Observed Treatment, Short-course), BCG vaccination at birth.

Viral Hepatitis

Agent: Hepatoviruses (Types A, B, C, D, E)

Transmission: Fecal-oral (A, E) or Blood/Sexual fluids (B, C, D).

Key Signs: Jaundice (yellow skin/eyes), dark urine, hepatomegaly, fatigue. B & C cause chronic cirrhosis and liver cancer.

Control: Vaccines for Hep A & B. Safe sex/clean needles (B, C). WASH practices (A, E).

Food Poisoning

Agent: Pre-formed toxins (Staphylococcus aureus, Bacillus cereus)

Transmission: Ingestion of contaminated, improperly stored food.

Key Signs: Rapid onset (1-6 hours) of acute nausea, vomiting, and abdominal cramps. Usually afebrile.

Control: Food safety standards, refrigeration (avoiding the 5°C-60°C danger zone), preventing cross-contamination.

Typhoid Fever

Agent: Salmonella Typhi (Bacteria)

Transmission: Fecal-oral route (contaminated food/water).

Key Signs: Progressive “step-ladder” fever pattern, rose spots on the trunk, abdominal pain, relative bradycardia.

Control: Typhoid Conjugate Vaccine (TCV), strict WASH protocols, carrier identification.

Intestinal Worms (STH)

Agent: Soil-Transmitted Helminths (Ascaris, Hookworm, Trichuris)

Transmission: Fecal-oral (ingesting soil/eggs) or direct skin penetration (Hookworm).

Key Signs: Malnutrition, severe iron deficiency anemia (Hookworm), abdominal pain, stunted growth.

Control: Biannual mass deworming (Albendazole), ending open defecation, wearing shoes.

Acute Diarrheal Diseases

Agent: Various (Rotavirus, Vibrio cholerae, E. coli)

Transmission: Fecal-oral route via contaminated water/food.

Key Signs: Passage of 3 or more loose/watery stools a day. Rapid, lethal dehydration (especially Cholera).

Control: Oral Rehydration Solution (ORS), Zinc supplementation, Rotavirus vaccine, boiling water.

Lymphatic Filariasis

Agent: Wuchereria bancrofti (Parasitic nematode)

Transmission: Bite of infected Culex mosquito.

Key Signs: Damage to the lymphatic system causing severe, irreversible lymphedema, elephantiasis of limbs, and hydrocele (scrotal swelling).

Control: Mass Drug Administration (MDA) using DEC and Albendazole. Morbidity management.

Leishmaniasis (Kala-azar)

Agent: Leishmania donovani (Protozoa)

Transmission: Bite of infected female Phlebotomine sandfly.

Key Signs: Prolonged irregular fever, massive splenomegaly/hepatomegaly, weight loss, pancytopenia. Almost 100% fatal if untreated.

Control: Indoor Residual Spraying (IRS), early diagnosis (rK39 test) and treatment.

Malaria

Agent: Plasmodium species (P. falciparum is deadliest).

Transmission: Bite of infected female Anopheles mosquito.

Key Signs: Cyclical paroxysms consisting of cold stage (chills), hot stage (fever), and sweating stage. Severe anemia, cerebral malaria.

Control: LLINs (Long-Lasting Insecticidal Nets), IRS, Rapid Diagnostic Tests, ACT treatment.

Japanese Encephalitis (JE)

Agent: JE Virus (Flavivirus)

Transmission: Culex mosquito bites. Pigs and wading birds act as amplifying hosts.

Key Signs: Acute inflammation of the brain (encephalitis), high fever, neck stiffness, seizures, coma. High mortality/disability rate.

Control: Live attenuated JE Vaccine, vector control around agricultural/piggery zones.

Rabies

Agent: Rabies virus (Rhabdovirus)

Transmission: Saliva from bite or scratch of a rabid animal (dogs cause 99% of human cases in Nepal).

Key Signs: Hydrophobia (fear of water), aerophobia, hyperactivity, fatal encephalomyelitis. 100% fatal once clinical signs appear.

Control: Mass dog vaccination. Post-Exposure Prophylaxis (PEP) vaccine and Rabies Immunoglobulin (RIG).

Tetanus

Agent: Clostridium tetani (Bacteria)

Transmission: Environmental spores (soil/dust) contaminating necrotic wounds or unhygienic umbilical cord cutting.

Key Signs: Severe muscle spasms triggered by toxins. Jaw cramping (lockjaw/trismus), back arching (opisthotonos).

Control: TT/Td Vaccination (pregnant women, children, post-injury), clean wound management.

Trachoma

Agent: Chlamydia trachomatis (Bacteria)

Transmission: Direct contact with eye/nose discharge, or mechanically via flies.

Key Signs: Chronic conjunctivitis leading to inward-turning eyelashes (trichiasis), which scrape the cornea causing irreversible blindness.

Control: SAFE Strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement).

Leprosy (Hansen’s Disease)

Agent: Mycobacterium leprae

Transmission: Prolonged close contact, likely via respiratory droplets.

Key Signs: Hypopigmented skin patches with definite loss of sensation, thickened peripheral nerves, secondary tissue deformities.

Control: Multi-Drug Therapy (MDT) to cure patients and halt transmission; early detection.

STDs (Syphilis, Gonorrhea)

Agent: Treponema pallidum (Syphilis), Neisseria gonorrhoeae.

Transmission: Unprotected vaginal, anal, or oral sexual contact. Vertical (mother-to-child).

Key Signs: Painless ulcer (Syphilis primary chancre), purulent urethral discharge (Gonorrhea). Can lead to Pelvic Inflammatory Disease.

Control: Syndromic management protocol, condom promotion, contact tracing.

HIV/AIDS

Agent: Human Immunodeficiency Virus (Retrovirus)

Transmission: Blood (shared needles), unprotected sex, Mother-to-Child (PMTCT).

Key Signs: Destruction of CD4 T-cells leading to immunodeficiency. Susceptibility to opportunistic infections (TB, Kaposi’s sarcoma).

Control: Antiretroviral Therapy (ART) achieving “Undetectable = Untransmittable”, Pre-Exposure Prophylaxis (PrEP), Condoms.

COVID-19

Agent: SARS-CoV-2 (Coronavirus)

Transmission: Airborne respiratory aerosols and droplets. Fomites.

Key Signs: Fever, dry cough, anosmia (loss of smell), fatigue. Severe cases progress to Acute Respiratory Distress Syndrome (ARDS).

Control: mRNA/Vector Vaccines, NPIs (masking, social distancing, ventilation), case isolation.

50 Key Points on Communicable Diseases

1. Measles is a highly contagious viral respiratory disease characterized by Koplik’s spots and a maculopapular rash.

2. Diphtheria is caused by Corynebacterium diphtheriae, producing a pseudomembrane in the throat and severe exotoxins.

3. Whooping cough (Pertussis) is caused by Bordetella pertussis, characterized by severe coughing paroxysms ending in a “whoop”.

4. Rubella (German Measles) is generally mild but causes Congenital Rubella Syndrome (CRS) if contracted during early pregnancy.

5. Mumps primarily affects the parotid salivary glands and can cause orchitis (testicular inflammation) in post-pubertal males.

6. Tetanus is caused by Clostridium tetani spores infecting wounds, causing muscle stiffness and lockjaw (trismus).

7. Neonatal tetanus, once a major killer in Nepal, has been eliminated via clean delivery practices and maternal TT/Td vaccination.

8. Acute Respiratory Infections (ARI), particularly pneumonia, remain a leading cause of under-5 mortality globally.

9. Influenza viruses undergo antigenic drift (minor changes) and antigenic shift (major changes leading to pandemics).

10. The basic reproduction number (R0) of Measles is exceedingly high (12-18), requiring ~95% vaccine coverage for herd immunity.

11. Tuberculosis (TB) is caused by Mycobacterium tuberculosis, primarily transmitted via airborne droplet nuclei.

12. Directly Observed Treatment, Short-course (DOTS) is the internationally recommended strategy for TB control.

13. Multi-Drug Resistant TB (MDR-TB) is resistant to at least Isoniazid and Rifampicin, the two most powerful first-line drugs.

14. Leprosy (Hansen’s disease) is caused by Mycobacterium leprae, affecting skin and peripheral nerves, leading to deformities if untreated.

15. Multi-Drug Therapy (MDT) for leprosy consists of Rifampicin, Dapsone, and Clofazimine, provided free of cost.

16. COVID-19, caused by SARS-CoV-2, is primarily transmitted via respiratory droplets and aerosols.

17. Non-Pharmaceutical Interventions (NPIs) like social distancing and masking were primary controls for COVID-19 before vaccines.

18. Malaria is caused by Plasmodium parasites, transmitted exclusively by the bite of infected female Anopheles mosquitoes.

19. Plasmodium falciparum causes the most severe, often fatal, cerebral malaria.

20. Long-Lasting Insecticidal Nets (LLINs) and Indoor Residual Spraying (IRS) are core malaria vector control interventions.

21. Japanese Encephalitis (JE) is a viral brain infection transmitted by Culex mosquitoes, with pigs and wading birds as amplifying hosts.

22. Lymphatic Filariasis (Elephantiasis) is caused by Wuchereria bancrofti roundworms, transmitted by Culex mosquitoes in Nepal.

23. Mass Drug Administration (MDA) using DEC and Albendazole is the primary strategy to eliminate Lymphatic Filariasis.

24. Leishmaniasis (Kala-azar) is caused by protozoan parasites transmitted by the bite of infected female phlebotomine sandflies.

25. Kala-azar primarily affects the reticuloendothelial system (spleen, liver, bone marrow) and is fatal if untreated.

26. Post-Kala-azar Dermal Leishmaniasis (PKDL) is a complication that serves as an inter-epidemic reservoir for the parasite.

27. Acute Diarrheal Diseases (ADD) cause severe dehydration; Oral Rehydration Solution (ORS) is the life-saving treatment.

28. Zinc supplementation for 10-14 days significantly reduces the duration and severity of childhood diarrheal episodes.

29. Typhoid fever is a systemic infection caused by Salmonella Typhi, transmitted via the fecal-oral route.

30. A classic sign of Typhoid fever is a step-ladder fever pattern and rose spots on the abdomen.

31. Food poisoning is rapidly onset illness caused by pre-formed bacterial toxins (e.g., Staph aureus, Bacillus cereus) in food.

32. Soil-Transmitted Helminths (Intestinal worms like Ascaris, Hookworm) cause malnutrition, anemia, and growth retardation.

33. Hookworms physically attach to the intestinal wall and feed on blood, leading directly to iron deficiency anemia.

34. Biannual deworming (Albendazole) of school-aged children is a highly cost-effective public health intervention.

35. HIV (Human Immunodeficiency Virus) attacks CD4 T-cells, severely weakening the immune system leading to AIDS.

36. HIV is transmitted via unprotected sex, contaminated blood/needles, and from mother-to-child (PMTCT).

37. Antiretroviral Therapy (ART) suppresses viral replication, allowing people with HIV to live normal lifespans and preventing transmission (U=U).

38. Syphilis is an STD caused by Treponema pallidum, progressing through primary (chancre), secondary, and tertiary stages.

39. Gonorrhea and Chlamydia are bacterial STDs that can cause Pelvic Inflammatory Disease (PID) and infertility in women.

40. Syndromic Management is the standard WHO approach for treating STDs in resource-limited settings based on symptom clusters.

41. Viral Hepatitis A and E are transmitted via the fecal-oral route (contaminated water/food).

42. Viral Hepatitis B and C are transmitted via blood and body fluids and can cause chronic liver cirrhosis and hepatocellular carcinoma.

43. Rabies is a 100% fatal zoonotic viral encephalitis, primarily transmitted in Nepal by dog bites.

44. Immediate wound washing with soap and water for 15 minutes is the crucial first aid for any animal bite to prevent Rabies.

45. Post-Exposure Prophylaxis (PEP) for Rabies involves a series of cell-culture vaccines and, for severe bites, Rabies Immunoglobulin (RIG).

46. Trachoma is a bacterial eye infection (Chlamydia trachomatis) leading to blindness; Nepal successfully eliminated it as a public health problem.

47. The SAFE strategy for Trachoma: Surgery, Antibiotics, Facial cleanliness, Environmental improvement.

48. Contact tracing is an epidemiological tool to identify and isolate individuals who have been exposed to a communicable disease.

49. Active surveillance involves health workers actively searching for cases, critical during outbreaks like Cholera or COVID-19.

50. The incubation period is the time between exposure to the pathogen and the onset of clinical symptoms.

6.2 Prevention and Control of Non-Communicable Diseases (NCDs)

Non-communicable diseases (NCDs), also known as chronic diseases, are of long duration and generally slow progression. Over the past century, public health has witnessed the Epidemiological Transition—a massive shift in mortality causes from acute infectious diseases to chronic, lifestyle-driven NCDs. The four main types are cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes.

The Epidemiological Transition

As nations develop, mortality shifts from infectious diseases to chronic NCDs.

The 4 Modifiable Risk Factors Driving NCDs

Tobacco Use

Primary driver of lung cancers and COPD.

Harmful Alcohol

Linked to liver disease, CVD, and certain cancers.

Unhealthy Diet

High salt, sugar, trans fats drive obesity/diabetes.

Physical Inactivity

Sedentary lifestyle severely increases CVD risk.

50 Key Points on NCDs

51. NCDs account for over 70% of all deaths globally, shifting the burden away from infectious diseases.

52. Cardiovascular Diseases (CVDs) are the number one cause of NCD deaths globally.

53. Hypertension (high blood pressure) is the leading metabolic risk factor for NCDs, often called the “silent killer.”

54. Normal blood pressure is defined as < 120/80 mmHg; hypertension is formally diagnosed at >= 140/90 mmHg.

55. Ischemic heart disease (e.g., heart attacks) occurs when blood flow to the heart muscle is restricted by plaque.

56. Stroke (cerebrovascular accident) occurs when blood supply to part of the brain is interrupted or reduced.

57. Rheumatic Heart Disease (RHD) is an NCD caused by untreated streptococcal throat infections during childhood, still prevalent in Nepal.

58. The WHO PEN (Package of Essential Non-communicable Disease Interventions) is a strategy for NCD care in primary health settings.

59. Nepal’s Multi-Sectoral Action Plan for Prevention and Control of NCDs focuses heavily on the 4 major NCDs and 4 shared risk factors.

60. Reducing dietary sodium (salt) intake is one of the most cost-effective ways to reduce population blood pressure.

61. Type 1 Diabetes is an autoimmune condition where the pancreas produces little to no insulin.

62. Type 2 Diabetes accounts for >90% of cases and is largely the result of excess body weight and physical inactivity.

63. Uncontrolled diabetes leads to microvascular complications: retinopathy (blindness), nephropathy (kidney failure), and neuropathy.

64. Gestational diabetes occurs during pregnancy and increases the lifelong risk of Type 2 diabetes for the mother.

65. Chronic Obstructive Pulmonary Disease (COPD) is a progressive, irreversible lung disease causing breathing difficulty.

66. In Nepal, indoor air pollution from biomass fuels (wood/dung) is a massive driver of COPD, especially among rural women.

67. Asthma is a chronic inflammatory disease of the airways, characterized by reversible airflow obstruction and bronchospasm.

68. Unlike COPD, asthma usually begins in childhood and is strongly associated with allergies and environmental triggers.

69. Primary prevention of COPD focuses entirely on smoking cessation and replacing open-fire cooking stoves with clean energy.

70. Fasting blood sugar >= 126 mg/dL on two separate tests is diagnostic for diabetes.

71. Cancer is the rapid creation of abnormal cells that grow beyond their usual boundaries, capable of metastasizing.

72. Lung cancer is the leading cause of cancer death globally, overwhelmingly caused by tobacco smoking.

73. Cervical cancer is a leading cancer among women in Nepal, primarily caused by persistent HPV infection.

74. Cervical cancer is highly preventable through HPV vaccination of adolescent girls and regular Pap smear/VIA screening.

75. Breast cancer screening involves breast self-examination, clinical breast examination, and mammography.

76. Oral cancer rates are exceedingly high in South Asia due to the widespread cultural practice of chewing tobacco and betel nut (Gutkha).

77. Early detection through screening (secondary prevention) dramatically increases cancer survival rates.

78. Palliative care is a crucial component of NCD management, focusing on improving the quality of life for terminal patients.

79. Mental health disorders (Depression, Anxiety) are heavily integrated into the NCD burden, causing severe disability.

80. Suicide prevention is a key mental health objective, requiring destigmatization and accessible psychosocial support.

81. The four main modifiable behavioral risk factors are: tobacco use, physical inactivity, unhealthy diet, and harmful use of alcohol.

82. “Best Buys” are WHO-recommended, highly cost-effective interventions for NCDs (e.g., increasing tobacco taxes).

83. Tobacco taxation is proven to be the single most effective measure to reduce smoking rates, especially among youth.

84. Graphic health warnings on tobacco packaging significantly deter new smokers and encourage quitting.

85. Trans fats must be legally eliminated from the industrial food supply to prevent millions of ischemic heart disease deaths.

86. Sugar-sweetened beverage (SSB) taxes are increasingly used to combat the childhood obesity epidemic.

87. WHO recommends at least 150 minutes of moderate-intensity aerobic physical activity throughout the week for adults.

88. Body Mass Index (BMI) and Waist Circumference are the primary population-level screening tools for obesity risk.

89. Genetic/Family history is a non-modifiable risk factor for almost all major NCDs.

90. Aging is a non-modifiable risk factor; as life expectancy increases globally, NCD prevalence naturally rises.

91. Chronic Kidney Disease (CKD) is an increasingly prevalent NCD, often a downstream complication of diabetes and hypertension.

92. Road traffic injuries, while not traditional NCDs, are often grouped with them in public health prevention planning due to behavioral factors.

93. Osteoporosis is a chronic condition characterized by decreased bone density, leading to fragility fractures in the elderly.

94. Secondary prevention of NCDs involves treating individuals who have had a primary event (e.g., aspirin after a heart attack).

95. Task-shifting (training nurses/paramedics to manage basic NCD care) is vital in resource-limited settings like Nepal.

96. Air pollution (PM2.5) is now recognized as a major independent risk factor for stroke, heart disease, and lung cancer.

97. NCDs disproportionately affect low- and middle-income countries (LMICs), causing devastating economic impacts at the household level.

98. Universal Health Coverage (UHC) is essential to ensure chronic NCD patients do not face catastrophic out-of-pocket health expenditures.

99. Population-based salt reduction strategies include reformulating processed foods and public awareness campaigns.

100. Multisectoral action is required for NCDs; health ministries alone cannot control urban planning (physical activity) or food industry regulations.

6.3 Sickle Cell Anemia and Thalassemia

Sickle Cell Anemia and Thalassemia are inherited blood disorders affecting hemoglobin. In Nepal, Sickle Cell is a major public health issue uniquely concentrated within the indigenous Tharu community of the Terai region. The high prevalence here is a classic example of balanced polymorphism: the genetic trait provided historical protection against the lethal Plasmodium falciparum malaria that ravaged the region.

Normal Blood Vessel (HbAA)

Flexible, round cells flow freely, delivering oxygen to tissues.

Vaso-Occlusion in Sickle Cell (HbSS)

Rigid, sickle-shaped cells clump and block blood flow, causing severe pain crises.

Autosomal Recessive Inheritance Pattern

Carrier Father (HbAS)

Carrier Mother (HbAS)

25% Normal (HbAA)

50% Carrier Trait (HbAS)

25% Sickle Cell Disease (HbSS)

50 Key Points on Sickle Cell & Thalassemia

101. Sickle cell disease (SCD) is a genetic disorder causing red blood cells to deform into a rigid, sickle (crescent) shape.

102. The sickling is caused by a point mutation in the beta-globin gene, producing abnormal hemoglobin S (HbS).

103. Normal red blood cells live for ~120 days; sickle cells break down prematurely after 10-20 days, causing chronic hemolytic anemia.

104. Rigid sickle cells block small blood vessels (vaso-occlusion), halting oxygen delivery to tissues.

105. Vaso-occlusive crises (pain crises) are the hallmark clinical manifestation, causing excruciating pain in bones, chest, and abdomen.

106. Repeated blood vessel blockages lead to chronic organ damage, particularly to the spleen, kidneys, and brain.

107. Autosplenectomy occurs when the spleen infracts and shrinks due to repeated sickling, leaving patients highly vulnerable to bacterial infections.

108. Acute Chest Syndrome is a life-threatening complication of SCD, mimicking pneumonia but caused by sickling in the lungs.

109. Dactylitis (Hand-Foot Syndrome), painful swelling of hands and feet, is often the first clinical sign of SCD in infants.

110. Priapism (prolonged, painful erection) is a severe vaso-occlusive complication in males with SCD.

111. SCD follows an autosomal recessive inheritance pattern.

112. Individuals with one normal gene and one HbS gene have “Sickle Cell Trait” (HbAS) and are generally asymptomatic carriers.

113. If two carriers reproduce, there is a 25% chance of the child having the full disease (HbSS) with each pregnancy.

114. The sickle cell trait provides a survival advantage against severe Plasmodium falciparum malaria.

115. This genetic advantage explains why the sickle gene is highly prevalent in historically malaria-endemic regions (like Nepal’s Terai).

116. In Nepal, SCD is overwhelmingly concentrated in the indigenous Tharu community.

117. Endogamy (marrying strictly within the community) among the Tharu has maintained the high frequency of the mutant gene.

118. Lumbini province (e.g., Bardiya, Banke, Dang) has some of the highest prevalence rates of SCD in Nepal.

119. Thalassemia is another genetic blood disorder characterized by reduced production of normal hemoglobin (alpha or beta chains).

120. Beta-thalassemia major requires lifelong regular blood transfusions for survival.

121. The Sickling Test (using sodium metabisulfite) is a rapid screening tool that causes HbS to sickle under a microscope.

122. The Solubility Test is another rapid screen; HbS makes the solution turbid, while normal Hb remains clear.

123. Screening tests cannot differentiate between Sickle Cell Trait (carrier) and Sickle Cell Disease.

124. Hemoglobin Electrophoresis is the gold standard diagnostic test, accurately separating and quantifying HbA, HbS, and HbF.

125. High-Performance Liquid Chromatography (HPLC) is an advanced, highly accurate diagnostic method rapidly replacing standard electrophoresis.

126. Newborn screening for SCD allows for early intervention, drastically reducing infant mortality from early infections.

127. Prenatal diagnosis via amniocentesis can determine if a fetus has SCD before birth.

128. Peripheral blood smears of SCD patients show classic crescent-shaped cells and Howell-Jolly bodies (indicating a non-functioning spleen).

129. Thalassemia diagnosis also relies heavily on Hb Electrophoresis (showing elevated HbA2 or HbF) and Complete Blood Count (showing severe microcytic anemia).

130. Nepal’s government has initiated targeted screening programs specifically in Tharu-majority districts.

131. Hydroxyurea is a critical daily medication that increases Fetal Hemoglobin (HbF), significantly reducing the frequency of pain crises.

132. Prophylactic Penicillin given from 2 months to 5 years of age prevents fatal pneumococcal sepsis in SCD children.

133. Up-to-date vaccinations (especially Pneumococcal, Meningococcal, and Haemophilus influenzae) are mandatory for SCD patients due to spleen dysfunction.

134. Pain management during vaso-occlusive crises requires aggressive hydration and strong analgesics (often opioids).

135. Blood transfusions are used for severe anemia, acute chest syndrome, or stroke prevention in SCD.

136. Repeated blood transfusions (especially in Thalassemia) lead to iron overload, requiring chelation therapy to protect the heart and liver.

137. Bone Marrow Transplant (Stem Cell Transplant) is currently the only known definitive cure for SCD and Thalassemia, though risky and expensive.

138. Folic acid supplementation is routinely given to support the rapid red blood cell turnover in SCD patients.

139. Patients must avoid triggers for sickling: extreme cold, dehydration, high altitudes, and severe physical exertion.

140. Nepal’s Bheri Hospital (Nepalgunj) serves as a major referral hub for Sickle Cell management in Lumbini province.

141. Genetic counseling is the cornerstone of primary prevention for SCD and Thalassemia.

142. Pre-marital screening identifies carrier couples before they marry, allowing them to make informed reproductive choices.

143. If both partners are carriers, counselors explain the 25% risk to offspring and discuss options like prenatal testing or adoption.

144. Stigmatization of carriers is a major barrier to screening programs in rural communities.

145. “Sickle Cell Identity Cards” are issued in Nepal to streamline treatment access and verify carrier status.

146. The Nepal government provides a treatment subsidy (up to Rs. 100,000) for diagnosed SCD patients.

147. Public health campaigns must carefully decouple the disease from social stigma against the Tharu community.

148. School-based screening programs in endemic districts are an effective strategy to identify adolescent carriers early.

149. Thalassemia minor (carrier state) is often misdiagnosed as simple iron deficiency anemia because both cause microcytic red blood cells.

150. Expanding access to HPLC testing machines at provincial levels is critical to confirm rapid screening results.

6.4 Concept of Control, Elimination & Eradication

In public health, managing a disease occurs on a strict spectrum from Control to Extinction. To move a disease along this spectrum, robust Public Health Surveillance is required. Surveillance is not just data collection; it is a continuous loop of “information for action.”

The Surveillance Cycle

Data in, Public Health action out.

The Eradication Spectrum

1. Control Reduce incidence to locally acceptable level (e.g., Malaria). Interventions must continue.
2. Elimination Zero incidence in a defined geographic area (e.g., Polio in Americas). Vigilance required against importation.
3. Eradication Zero incidence GLOBALLY (e.g., Smallpox). Routine interventions can finally be stopped.
4. Extinction Pathogen completely destroyed, even in highly secure laboratories. (Has never happened).

50 Key Points on Control, Elimination & Eradication

151. Disease Control is the reduction of disease incidence, prevalence, morbidity, or mortality to a locally acceptable level.

152. Control requires continued, ongoing intervention measures to maintain the reduction.

153. If control measures are stopped, the disease will quickly rebound to previous levels.

154. Malaria is currently in the “control” phase in most endemic countries; we distribute nets and spray homes continuously.

155. Tuberculosis control relies on the DOTS strategy to cure infectious patients and stop transmission.

156. Diarrheal disease control relies on continuous WASH interventions and ORS distribution.

157. Control programs are heavily reliant on robust local primary healthcare systems.

158. The “acceptable level” in control varies depending on the country’s resources and health burden.

159. Control measures can be aimed at the agent (antibiotics), the host (vaccines), or the environment (sanitation).

160. Routine childhood immunization (EPI) is the ultimate ongoing control measure for vaccine-preventable diseases.

161. Elimination is the reduction to zero of the incidence of a specified disease in a defined geographical area.

162. Continued intervention measures are still required post-elimination to prevent re-establishment from imported cases.

163. Polio has been eliminated from the Americas and Europe, but routine vaccination must continue.

164. Measles has been eliminated in several countries, but outbreaks occur if vaccination rates drop and a case is imported.

165. “Elimination as a Public Health Problem” is a specific WHO term meaning incidence is reduced to a point where it is no longer a major burden.

166. Nepal declared the elimination of Leprosy as a public health problem in 2010 (prevalence < 1 per 10,000 population).

167. Nepal successfully eliminated Maternal and Neonatal Tetanus (MNT) in 2005.

168. Nepal eliminated Trachoma as a public health problem in 2018, recognized by the WHO.

169. Elimination requires a massive, coordinated effort and highly sensitive surveillance systems.

170. Lymphatic Filariasis is currently targeted for elimination as a public health problem in Nepal via MDA.

171. Eradication is the permanent reduction to zero of the worldwide incidence of infection caused by a specific agent.

172. Once a disease is eradicated, routine intervention measures (like mass vaccination) are no longer needed.

173. Smallpox is the only human disease to have ever been completely eradicated (certified in 1980).

174. Rinderpest is an animal disease (affecting cattle) that was declared globally eradicated in 2011.

175. For a disease to be eradicable, there must be an effective, practical intervention (like a highly effective vaccine).

176. To be eradicable, the disease must have no non-human animal reservoir (it must only infect humans).

177. The pathogen must not persist in the environment outside the human host for long periods.

178. The infection must produce clear, easily recognizable clinical symptoms (to identify and isolate cases easily).

179. Subclinical or asymptomatic carrier states make a disease extremely difficult to eradicate.

180. Polio and Guinea Worm Disease (Dracunculiasis) are currently the primary global targets nearing eradication.

181. Extinction means the specific infectious agent no longer exists in nature or in the laboratory.

182. No disease has reached extinction; smallpox virus stocks are still kept in highly secure labs in the US and Russia.

183. Surveillance is the continuous, systematic collection, analysis, and interpretation of health-related data.

184. Passive surveillance relies on hospitals/clinics routinely reporting cases to health authorities (HMIS in Nepal).

185. Active surveillance involves health staff visiting facilities or communities specifically searching for cases.

186. Sentinel surveillance uses selected institutions/clinics to monitor disease trends (e.g., monitoring flu strains).

187. Syndromic surveillance tracks symptom patterns (e.g., pharmacy sales for fever drugs) to detect outbreaks before formal diagnosis.

188. An outbreak or epidemic is the occurrence of disease cases in excess of normal expectancy in a community.

189. A pandemic is an epidemic occurring worldwide, or over a very wide area, crossing international boundaries.

190. Endemic refers to the constant presence and/or usual prevalence of a disease within a geographic area.

191. The first step in an outbreak investigation is to establish the existence of the outbreak (verify baseline levels).

192. Verifying the diagnosis is the crucial second step to ensure the reported cases are actually the suspected disease.

193. A case definition is a standard set of criteria for deciding whether an individual should be classified as having the health condition.

194. An Epidemic Curve is a histogram showing the course of a disease outbreak over time, helping identify the type of exposure.

195. A point-source outbreak (e.g., food poisoning at a wedding) shows a sharp, sudden peak on the epidemic curve.

196. A propagated outbreak (person-to-person spread like measles) shows a series of progressively taller peaks on the curve.

197. Herd immunity is the indirect protection from an infectious disease occurring when a large percentage of a population becomes immune.

198. The index case is the first disease case in an epidemic to be noticed by health authorities.

199. Quarantine applies to separating *healthy* people who have been exposed; Isolation applies to separating *sick* people.

200. Disease eradication yields massive long-term economic benefits (return on investment), as prevention costs drop to zero.

Knowledge Check: 100 MCQs

Test your knowledge on Epidemiology & Disease Control. Click an option to see if you’re correct.

6.1 Communicable 6.2 Non-Communicable 6.3 Sickle Cell 6.4 Eradication